Shen Song^1*, Keith D Burau, PhD^2*, Shenying Fang, MD, MS^3*, Haijun Wang, PhD^4*, Xianglin L Du, MD, PhD^3* and Luhua Wang, MD⁵

¹Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Biostatistics, University of Texas School of Public Health, Houston, TX
³Division of Epidemiology, University of Texas School of Public Health, Houston, TX
⁴Department of Family and Community MedicineHouston, Baylor College of Medicine, Houston, TX
⁵M.D. Anderson Cancer Center, Houston, TX

Bhawna Sirohi¹, Raymond Powles, MD², Dietger Niederweiser^3*, Norm Coleman^4*, Nelson J. Chao, MD⁵, Judith Bader^6*, Cullen Case Jr.^7*, John Chute, MD⁸, Dennis L. Confer, MD⁹, Patrick Gourmelon^10*, Norbert C Gorin¹¹, Arnold Ganser, MD, PhD¹², Matthias Port^13*, Viktor Meineke^14*, Robert Krawisz^15*, David M Weinstock, MD¹⁶, Albert Wiley, MD, PhD^17* and Ted Fliedner^18*

¹Addenbrookes hopsital, Cambridge, United Kingdom
²Oncology-Prot R Powles, Parkside Oncology Clinic, Wimbledon, ARRAY(0xa087f20)
³University of Leipzig, Leipzig
⁴NIH/NCI,
⁵Med./Div. of Cellular Therapy, Duke University Med. Ctr., Durham, NC
⁶NIH/NCI
⁷National Marrow donor Program
⁸Div. of Cellular Therapy, Duke University, Durham, NC
⁹National Marrow Donor Program, Minneapolis, MN
¹⁰IRSN, France
¹¹Hematology-Oncology, Hopital Saint-Antoine and Université Pierre et Marie Curie UPMC, Paris, France
¹²Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹³Hanover medical school
¹⁴Bundeswehr University
¹⁵ASBMT
¹⁶Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁷REAC/TS, Oak Ridge, TN
¹⁸University of Ulm

Ambuj Kumar, MD, MPH^1*, Iztok Hozo, Professor, of, Mathematics, Ph.D^2* and Benjamin Djulbegovic, MD, PhD³

¹Moffitt Cancer Center, Tampa, FL
²Department of Mathematics and Actuarial Science, Indiana University, Gary, IN
³Health Outcomes and Behavior, Hematology, Moffitt Cancer Center, Tampa, FL

Esther Natalie Oliva, MD¹, Cristina Clissa, MD^2*, Valeria Santini^3*, Antonella Poloni, MD^4*, Vincenzo Liso, MD^5*, Daniela Cilloni, MD, PhD⁶, Adelmo Terenzi, MD^7*, Stefana Impera, MD^8*, Alessandro Levis, MD⁹, Agostino Cortelezzi, MD^10*, Riccardo Ghio, MD^11*, Giampietro Semenzato, MD^12*, Oreste Villani, MD^13* and Maria Antonietta Aloe Spiriti, MD^14*

¹Hematology, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
²Hematology, Ospedale Sant'Orsola Malpighi, Bologna, Italy
³Hematology, Azienda Ospedaliera Careggi, Firenze, Italy
⁴Hematology, Ospedale di Torrette di Ancona, Ancona, Italy
⁵Hematology, Università degli Studi di Bari, Bari, Italy
⁶dept of Clinical and Biological Sciences, University of Turin, Turin, Italy
⁷Oncology and Hematology Department, A.O. Silvestrini, Perugia, Italy
⁸Hematology, Presidio Ospedaliero Garibaldi-Nesima, Catania, Italy
⁹Ospedale Civile, Alessandria, Italy
¹⁰Department of Medical Science - O.U. Hematology 1, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena and University of Milan, Milan, Italy
¹¹Hematology, Ospedale San Martino, Genova, Italy
¹²Sperimental Clinical Medicine, Università degli Studi di Padova, Padova, Italy
¹³Hematology, Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, Italy
¹⁴Hematology, A.O. Sant'Andrea, Roma, Italy

Marjolein Pompen, PhD^1* and P.C. Huijgens, MD, PhD²

¹Roche Netherlands, Woerden, Netherlands
²Dept. of Hematology, VU Medical Center, Amsterdam, Netherlands

Kristjan Paulson, MD^1*, Pascal Lambert, MSc^2*, David Szwajcer, MD, FRCP(C)², Janet Nowatzki^2*, Christopher Bredeson, MD, MSc, FRCP(C)^3*, Erin Richardson^2*, Morel Rubinger, MD, FRCPC⁴ and Matthew D. Seftel, MBChB, FRCP(C), MRCP⁵

¹Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
²CancerCare Manitoba, Winnipeg, MB, Canada
³Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Cancercare Manitoba, Winnipeg, MB, Canada
⁵Cancer Care Manitoba, Winnipeg, MB, Canada

Axel C. Muehlbacher^1*, Karsten Berndt^2*, Carl Hubertus Schreder^2* and Matthias Nuebling^3*

¹IGM Institut Gesundheitsökonomie und Medizinmanagement, Hochschule Neubrandenburg, D-17003 Neubrandenburg, Germany
²Health Economics & Pricing, Janssen-Cilag GmbH, D - 41470 Neuss, Germany
³GEB mbH: Empirical Consulting, D-79211 Denzlingen, Germany

Hermann Brenner^1*, Adam Gondos^1* and Dianne Pulte, MD²

¹German Cancer Research Center, Heidelberg, Germany
²VA New York Harbor Health Care System, New York, NY

Nancy A Brandenburg, PhD^1*, Thomas F Goss, PharmD^2*, Tyler Knight, MS^2*, Xiao Xu, PhD^2* and Robert D. Knight, MD³

¹Global Drug Safety, Celgene Corporation, Summit, NJ
²Covance, Inc., Gaithersburg, MD
³Celgene Corporation, Summit, NJ

Lauren Pinter-Brown, MD, FACP¹, Tami Wisniewski, MPH^2*, Bozena Katic, MPH/MPA^3*, Sheenu Chandwani, MPH^4* and Ya-Ting Chen, PhD^2*

¹Department of Internal Medicine, University of California at Los Angeles, Los Angeles, CA
²Global Outcomes Research, Merck & Co., Inc., Whitehouse Station, NJ
³School of Pharmacy, Temple University, Philadelphia, PA
⁴Pharmacy Practice and Administration, Rutgers University, Piscataway, NJ

Francesca D'Alessandro^1*, Antonella Tancredi^1*, Letizia Lombardini^1*, Silvia Pisanu^1*, Elisa Faraci^1*, Giorgia Santangelo^1*, Erica Villa^2*, Sante Venettoni^1* and Alessandro Nanni Costa^1*

¹Centro Nazionale Trapianti, Istituto Superiore Sanità, Roma, Italy
²Not listed, Not listed, Not listed, Italy

Martina Kleber¹, Gabriele Ihorst^2*, Barbara Deschler^1*, Christian Jakob, MD³, Peter Liebisch^4*, Bernd Koch^5*, Orhan Sezer^6* and Monika Engelhardt¹

¹Hematology and Oncology, University of Freiburg, Freiburg, Germany
²Department of Statistics and Biometry/Center of Clinical trials (ZKS), University of Freiburg, Freiburg, Germany
³Charite - Centrum für Tumormedizin, Med. Klinik m.S. Hämatologie/Onkologie, Berlin, Germany
⁴University Hospital, Ulm, Germany
⁵Central Laboratory, Medical Center Freiburg, University of Freiburg, Freiburg, Germany
⁶Charité-Centrum für Tumormedizin, Med. Klinik m.S. Hämatologie/Onkologie, Berlin, Germany

Elise M Pelletier, M.S.^1*, Paula J Smith, M.S.^1* and Carole J Dembek, M.S.^2*

¹Health Economics and Outcomes Research, IMS Consulting, Watertown, MA
²Global Health Outcomes & Strategic Pricing, Genzyme Corporation, Cambridge, MA

Carla M. Van Bennekom, M.P.H.^1*, Noopur Raje, MD^2*, Kenneth C. Anderson, M.D.^3*, Theresa E. Anderson, R.N.^1* and David W. Kaufman, ScD¹

¹Slone Epidemiology Center, Boston University, Boston, MA
²Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
³Dana Farber Cancer Institute, Boston, MA

Pierre K Isogai, B.Sc^1*, Matthew Cheung, MD² and Nicole Mittmann, MSc, PhD^3*

¹HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
²Sunnybrook Health Sciences Centre, Toronto, ON, Canada
³Clinical Pharmacology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Gebra Cuyun Carter, PhD, MPH^1*, Astra M Liepa, PharmD^1*, Anna Hayden Zimmermann, MS^2* and Franck Morschhauser, MD^3*

¹Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN
²Statistics, Eli Lilly and Company, Indianapolis, IN
³Hematology, Centre Hospitalier Universitaire, Lille, France

Chitra Hosing, MD¹, Veronica R. Smith, APN^2*, Beverly A. Rhodes, APN^2*, Kent H. Walters^2*, Muzaffar H. Qazilbash, MD³, John D. McMannis, PhD⁴, Amin M. Alousi^5*, Marcos De Lima^6*, Partow Kebriaei⁷, Sergio Giralt, MD¹, Issa Khouri^8*, Richard Champlin^9* and Uday Popat, MD¹⁰

¹M.D. Anderson Cancer Center, Houston, TX
²Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, Houston, TX
³BMT Unit 423, UT M.D. Anderson Cancer Ctr., Houston, TX
⁴M.D. Anderson Cancer Ctr., Houston, TX
⁵Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁶Stem Cell Trans./Stem Therapy, Univ. of Texas, Houston, TX
⁷Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Stem Cell Transplantation & Cell Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹MD Anderson Cancer Center, Houston, TX
¹⁰UT MD Anderson Canc. Cntr., Houston, TX

Ian H Gabriel, Dr^1*, Juliet Sharon^1*, Eduardo Olavarria, MD^2*, Amin Rahemtulla^1*, Edward Kanfer^1*, David Marin^1*, Dragana Milojkovic^1*, Katayoun Rezvani, MD, PhD³, Donald MacDonald^1* and Richard M. Szydlo^4*

¹Department of Hematology, Imperial College NHS trust, Hammersmith hospital, London, United Kingdom
²Hammesrsmith Hospital, London, United Kingdom
³Department of Haematology, Imperial College London, London, United Kingdom
⁴Dept. of Hematology, Hammersmith Hospital, London, United Kingdom

Lucien Noens^1*, Marie-Anne van Lierde^2*, Robrecht De Bock^3*, Gregor Verhoef^4*, Pierre Zachee⁵, Zwi Berneman⁶, Philippe Martiat⁷, Philippe Mineur^8*, Koen Van Eygen^9*, Karen MacDonald^10*, Sabina De Geest^11*, Tara Albrecht^12*, Laurie Letvak¹³ and Ivo Abraham^14*

¹UZ Gent, Gent, Belgium
²Novartis Pharm, Vilvoorde, Belgium
³ZNA Middelheim, Antwerpen, Belgium
⁴University Hospital, Leuven, Belgium
⁵Dept. of Hem./Onc., ZNA Stuivenberg, Antwerp, Belgium
⁶UZA, Antwerpen, Belgium
⁷Institut Jules Bordet, Brussels
⁸Hopital St. Joseph, Gilly, Belgium
⁹AZ Groeninge, Kortrijk, Belgium
¹⁰Matrix45, Earlysville, VA
¹¹University of Basel, Basel, Switzerland
¹²Matrix45 & University of Virginia, Earlysville, VA
¹³Novartis Oncology, East Hanover, NJ
¹⁴Matrix45, University of Arizona, & University of Pennsylvania, Earlysville, VA

Bruce Feinberg^*, James Gilmore^*, Sally Haislip^*, Carlos M. Franco, MD, Tom Gondesen^* and Mansoor N. Saleh, MD^*

Georgia Cancer Specialists, Atlanta, GA

Jane Dabney^1*, Lisa Rybicki^1*, Linda McLellan^1*, Larry Foster^2*, Michelle Visnosky^1*, Julie Curtis^1* and Brian Bolwell¹

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²School of Social Work, Cleveland State University, Cleveland, OH

Jane Dabney^1*, Lisa Rybicki^1*, Linda McLellan^1*, Larry Foster^2*, Michele Visnosky^1*, Julie Curtis^1* and Brian Bolwell¹

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²School of Social Work, Cleveland State University, Cleveland, OH

Jonathan A Gutman, MD¹, Amy L Olson, MD, MSPH^2*, Stephanie J. Lee, MD, MPH³, Rainer F. Storb, MD³, Brenda M. Sandmaier, MD⁴, Frederick R. Appelbaum, MD⁵ and Colleen Delaney, MD, MSC¹

¹Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
²National Jewish Medical and Research Center, Denver, CO
³Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA

Dorte Tholstrup, MD^1*, Jesper Jurlander, MD, PhD^1*, Palle Bekker Jeppesen, MD, PhD, DrMSci^2* and Peter de Nully Brown, MD, PhD^1*

¹Dept. of Hematology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
²Dept. of Gastroenterology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark

Vanderson Rocha, MD, PhD¹, Mutlu Arat, MD², Vladimir Koza, MD^3*, Norbet C Gorin^4*, Augustin Ferrant^5*, Kerstin Schäfer-Eckart^6*, Freja Ebeling^7*, Giuseppe Milone, medical, director⁸, Paolo de Fabritiis^9*, Leo Verdonck^10*, Alberto Bosi^11*, Jordi Esteve, MD¹², Bernardino Allione^13*, Johan Maertens^14*, Attilio Olivieri, MD¹⁵, Chiara Pilatrino^16*, Andree-Laure Herr-Bellon^1*, Fernando Pinto^1*, Celso Arrais^1*, Samir Nabhan^1*, Gerard Socié, MD, PhD^17*, Giorgio Dini^18*, Eliane Gluckman, MD¹⁹, Emmanuelle Polge^20* and Myriam Labopin^20*

¹BMT unit, Hopital Saint Louis APHP and University of Paris VII, Paris, France
²Dept. of Hematology, Ankara Univ. Faculty of Medicine, Ankara, Turkey
³Dept. of Hematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic
⁴Hematology-Oncology, Hopital Saint-Antoine and Université Pierre et Marie Curie UPMC, Paris, France
⁵European APL group, Bobigny, France
⁶Klinikum Nürnberg
⁷Helsinki University Central Hospital
⁸Hematology, Bone Marrow Unit, Catania, Italy
⁹Hematology, University Tor Vergata, Rome, Italy
¹⁰Haematology, University Medical Centre, Utrecht, Netherlands
¹¹Ospedale di Careggi, Florence, Italy
¹²Hematology, Hospital Clinic of Barcelona, Barcelona, Spain
¹³Ospedale Civile, Alessandria, Italy
¹⁴UZ Gasthuisberg, Leuven, Belgium
¹⁵Ospedale San Carlo, Potenza, Fano, Italy
¹⁶University of Turin
¹⁷Hematology / Transplantation, Hopital Saint-Louis, Paris, France
¹⁸G. Gaslini Children's Research Hospital
¹⁹Hopital Saint-Louis, Paris, France
²⁰EBMT Paris Office, Paris, France

Si-Tien Wang, BA, MS^1*, Mei Sheng Duh, MPH, ScD^2*, Hui Huang, PhD, MBA^3*, Leigh Ann White, PhD^1*, Eva Chang, MPH^1*, Dixie-Lee Esseltine, MD⁴ and Jing L. Marantz, MD, PhD⁵

¹Analysis Group, Boston, MA
²Analysis Group, Inc., Boston, MA
³Millennium Pharameuticals: The Takeda Oncology Company, Cambridge, MA
⁴Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA
⁵Global Medical Affairs, Millennium Pharmaceuticals: The Takeda Oncology Company, Cambridge, MA

Yvonne Daniel, MSc^1*, Charles Turner, BSc^2*, Lisa Farrar^3* and R. Neil Dalton, PhD^4*

¹Blood Sciences, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
²WellChild Laboratory, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
³Haematology, St James University Hospital, Leeds, United Kingdom
⁴WellChild Laboratory, King's College London, London, United Kingdom

Karen C Chung, PharmD, MS^1*, Arie Barlev, PharmD, MS^1*, Yi Qian, PhD^2* and Susie Jun, MD, PhD^3*

¹Global Health Economics, Amgen, Inc., Thousand Oaks, CA
²Global Biostatistics & Epidemiology, Amgen, Inc., Thousand Oaks, CA
³Oncology, Amgen, Inc., Thousand Oaks, CA

Kerry K Powell, MD^1*, Wei Wang, MS, MAS^2*, Kelly J Kelleher, MD, MPH^2* and Sarah H O'Brien, MD, MSc²

¹Division of Hematology/Oncology, Nationwide Children's Hospital, Columbus, OH
²Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children's Hospital, Columbus, OH

Gary H. Lyman, MD, MPH¹, David C. Dale, MD², Debra Wolff, MS, PCNP^1*, Eva Culakova, PhD, MS¹, Nicole M. Kuderer, MD¹, Marek S. Poniewierski, MD, MS¹ and Jeffrey Crawford, MD¹

¹Duke University, Durham, NC
²University of Washington, Seattle, WA

Youssef Sorour^1*, Stephen J Webber^2*, Josh G Wright^1*, Nicholas J Morley^1*, John T Reilly^1*, Christopher D Dalley^1* and John A Snowden^1*

¹Haematology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
²Department of Anaesthesia, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

Konstantinos Papadakis, MSc^1*, David Oscier^2*, Emma SC Carr, BSc, MSc, PhD^3*, Gavin Lewis^1* and Rick Aultman, MSc, Stats^3*

¹Healthcare Management, Roche Products Ltd, United Kingdom
²Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
³Pharmaceutics Division, PBSE, F. Hoffmann-La Roche AG, Basel, Switzerland

Maria Teresa Petrucci^1*, Elisabetta Calabrese^1*, Anna Levi^1*, Vincenzo Federico^1*, Michela Ceccolini^2*, Rita Rizzi^3*, Alessandro Gozzetti^4*, Patrizia Falco^5*, Maria Caterina Cavallo^6*, Simone Gerzelli^7*, Mario Boccadoro^5*, Francesco Lauria⁸, Vincenzo Liso^3*, Michele Cavo^2* and Robert Foa¹

¹Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy
²University of Bologna, Bologna, Italy
³Hematology, Università degli Studi di Bari, Bari, Italy
⁴Ematologia, Università di Siena, Siena, Italy
⁵Divisione di Ematologia dell'Università, A.O.U. San Giovanni Battista, Torino, Italy
⁶Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milano, Italy
⁷Department of Applied Statistics and Economics “Libero Lenti”, University, Pavia, Pavia, Italy
⁸University of Siena, Department of Hematology and Transplants, Siena, Italy

Bill Long^1*, Aliyah Rahemtullah, MD^2*, Christiana E. Toomey^3*, Adam Ackerman^2*, Jeremy S. Abramson, MD³ and Ephraim Hochberg, MD³

¹Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA
²Department of Pathology, Massachusetts General Hospital, Boston, MA
³Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA

Baris Deniz^1*, Thierry Facon^2*, Ian Singer^3*, Paul Micallef-Eynaud^4*, Ian Joseph^1*, Arran Shearer^5* and J. Jaime Caro^1*

¹United BioSource Corporation, Lexington, MA
²Service d'Hématologie, Centre Hospitalier Universitaire (CHU), Polonovski, France
³Monklands Hospital, Airdrie, United Kingdom
⁴Ayr Hospital, United Kingdom
⁵Celgene Corporation, Windsor Berkshire, United Kingdom

Emma Carr, PhD^1*, Susan Lerner, M.S., RHAI^2*, Rick Aultman, MSc^1*, Ute Weisgerber-Kriegl, PhD^1* and Michael Keating, MB, BS²

¹Pharmaceuticals Division, PBSE, F. Hoffmann-La Roche Ltd, Basel, Switzerland
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Bruce Feinberg, DO^1*, Jeffrey Scott, MD^2*, Susan Weidner^3* and Barry Fortner, PhD²

¹Georgia Cancer Specialists, Atlanta, GA
²Scientific Affairs and Provider Services, P4 Healthcare, Ellicott City, MD
³Eisai, INC., Bloomington, MN

Alhossain Khalafallah, MD¹, Kristina McDonnell^1*, Susie Shaw^1*, Hizb Dawar^1*, Michael Beamish^1*, Kim Rooney^1* and Damien Meagher^2*

¹Haematology, LGH, Launceston, Australia
²Haematology, Mersey Hospital, Latrobe, Australia

Christopher R Friese, RN, PhD, AOCN^1*, Gregory A Abel, MD, MPH^2*, Lysa S Magazu^2*, Bridget A Neville, MPH^2*, Nathanael D Hevelone, MPH^3*, Lisa C Richardson, MD⁴ and Craig C Earle, MD, MSc, FRCPC^5*

¹School of Nursing, University of Michigan, Ann Arbor, MI
²Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Surgery, University of California-San Francisco, San Francisco, CA
⁴Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Decatur, GA
⁵Institute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Baris Deniz^1*, Gareth Morgan^2*, Steve Schey^3*, Jack Ishak^4*, Peter Dale^5*, Arran Shearer^6* and J. Jaime Caro^1*

¹United BioSource Corporation, Lexington, MA
²The Royal Marsden Hospital, Surrey, United Kingdom
³Kings College Hospital, London, United Kingdom
⁴United BioSource Corporation, Montreal, QC, Canada
⁵United BioSource Corporation, London, United Kingdom
⁶Celgene Corporation, Windsor Berkshire, United Kingdom

Khalid El Ouagari, PhD^1*, Kimbach Tran, MPH, MS^2*, Jennifer Stephens, PharmD^2* and Marc Botteman, MSc, MA^2*

¹Novartis Pharmaceuticals Canada, Dorval, QC, Canada
²Pharmerit North America, LLC, Bethesda, MD

Elizabeth A Richey, BA^1*, Veena Shankaran, MD^1*, Steven Hirschfeld, MD, PhD^2*, Steven M Trifilio, RPh^3*, June McKoy, MD, MPH⁴, Kenneth R Carson, MD^5*, Beatrice J Edwards, MD, FACP^6*, Thanh Ha Luu, BA^1*, Narissa Nonzee, BS^1*, A. Oliver Sartor, MD^7* and Charles L. Bennett, MD, PhD, MPP¹

¹Hematology/Oncology, Northwestern University, Chicago, IL
²Nichd, NIH, Bethesda, MD
³Pharmacy, Northwestern Memorial Hospital, Chicago, IL
⁴Geriatrics, Northwestern University, Chicago, IL
⁵Hematology/Oncology, Siteman Comprehensive Cancer Center, Washington University School of Medicine, St. Louis, MO
⁶Bone Health and Osteoporosis Center, Northwestern University Feinberg School of Medicine, Chicago, IL
⁷Hematology/Oncology, Tulane University , Tulane Cancer Center, New Orleans, LA

Monica Boen, BA^1*, June McKoy, MD, MPH², Dennis West^1*, Beatrice Edwards^1*, Jayesh Mehta^1*, Seema Singhal³ and Charles L. Bennett, MD, PhD, MPP⁴

¹Feinberg School of Medicine, Northwestern University, Chicago, IL
²Northwestern University, Chicago, IL
³Hem./Onc., Northwestern Univ. Med. School, Chicago, IL
⁴Hematology/Oncology, Northwestern University, Chicago, IL

Dawn S Speckhart, Ph.D.^1*, H. Kent Holland, MD², Scott R. Solomon, MD^3*, Lawrence E. Morris², Asad Bashey, MD, PhD², Leslie Kerns, RN^1*, Tina Berry, MS^1* and Karen Manion, RN^1*

¹Bone Marrow Transplant/Acute Leukemia, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
²BMT Group of Georgia, Atlanta, GA
³The Blood and Marrow Transplant Group of Georgia, Atlanta, GA

Gene A. Wetzstein, PharmD, BCOP^1*, Jeffrey E. Lancet, MD^1*, Jennifer E. Kallner, PharmD^2*, Jeffrey M. Sivik, PharmD, BCOP^3*, Viet Q. Ho, PharmD, BCOP^4*, Timothy J. George, PharmD, BCOP^4*, Sheetal Desai, PharmD, BCOP^4*, Shanel Fisher, PharmD^4*, Michael D. Newton, PharmD, BCOP^5* and Alan F. List, MD¹

¹Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Indiana Oncology Hematology Consultants, Indianapolis, IN
³Penn State Milton S. Hershey Medical Center, Hershey, PA
⁴Pharmacy, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Health Sciences Center West Virginia University, Morgantown, WV

Michael R. Snell, M.D., PhD¹, Cecilia M. Choi, M.D.^2*, Shanmuga SP Subbiah, M.D.^2* and John D. Thornton, M.D., MPH^3*

¹Hematology/Oncology, MetroHealth Medical Center, Cleveland, OH
²Hematology/Oncology, University Hospitals Case Medical Center, Cleveland, OH
³Case Center for Reducing Health Disparities, Metrohealth Medical Center, Cleveland, OH

Khanh Tu Do, MD^1*, Geraldine P. Schechter, MD², Eric Nylen, MD^1*, Carlos Palant, MD^1* and Joao Ascensao, MD^2*

¹Internal Medicine and Hematology, Endocrinology, Nephrology Sections, George Washington University and VA Medical Center, Washington, DC
²VA Medical Center, Washington, DC

Loretta A Williams, PhD, RN¹, Patricia Ault, FNP-C^2*, Xin Shelley Wang, MD^3*, Charles S. Cleeland^3*, Tito R. Mendoza^3*, Gary M. Mobley^3* and Jorge E. Cortes³

¹Symptom Research, University of Texas M. D. Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³UT M.D. Anderson Cancer Center, Houston, TX

Jeffrey Alan Jones, MD, MPH, John C. Byrd, MD, Joseph M Flynn, DO, MPH and Craig Hofmeister, MD^*

Division of Hematology, Ohio State University Medical Center, Columbus, OH